World Health Organization
Avenue Appia 20
309 articles with World Health Organization
F4CP Applauds World Health Organization Highlighting Spinal Manipulation for Low Back Pain Over Drugs or Surgery
The Foundation for Chiropractic Progress, a not-for-profit organization dedicated to educating the public about the value of chiropractic care, applauds the recently published recommendations by the World Health Organization to manage low back pain initially with non-pharmaceutical interventions, such as spinal manipulation, while avoiding opioids, spinal injections and surgery.
As an Ebola outbreak rages on in the Congo with the highest mortality rate in history, AHF urges the World Health Organization (WHO) to expedite approval of a proven vaccine and declare an international emergency
CDC Foundation, Amgen Announce Program to Increase Awareness and Knowledge of Cardiovascular Diseases Globally
Global partnership seeks to improve health outcomes for people living with CVD in low- and middle-income countries
In the wake of the scandal caused by a Chinese researcher’s use of CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples, leading scientists called for a moratorium on heritable genome editing.
2/15/2019Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.
Chicago-based AbbVie just announced new data for its Mavyret (glecaprevir/pibrentasvir), a pan-genotypic treatment for chronic HCV in treatment-naive patients with compensated cirrhosis.
11/12/2018As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.
Two antimalarial strategies have been published from Imperial College London in the past month: new compounds that prevent the malaria parasite from infecting mosquitoes and gene-edited mosquitoes that cannot reproduce, leading to population destruction.
Temptime Corporation unveiled new technology today that will expand the range and flexibility of the company's Vaccine Vial Monitors (VVMs), which monitor the temperature exposure of vaccines to ensure that they have not been compromised by excessive heat.
ACG Inspection Partners with Verinetics to Further Strengthen Their Fight Against Falsified Medicines
ACG Inspection (ACGI) has partnered with CertiRx Corporation, d.b.a. “Verinetics” for further enhancing its Traceability and Authenticity solutions in the Track and Trace industry.
The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
New WHO INN stem "-fungerp" signifies a novel class of antifungals Novel generic name highlights the unique attributes of SCY-078 and its potential to address significant unmet needs across multiple indications
By using the xCELLigence instrument to monitor the attachment and growth of Acinetobacter baumannii in real-time, University of South Florida graduate student Jessie Adams has discovered key genes/proteins that enable this pathogen to persist in the surface-attached biofilm state.
Agile Sciences has developed a proprietary portfolio of small molecules of the 2-Aminoamidazole family (2-AI) that breaks the cycle of antibiotic resistance through a novel mode of action.
Research from Columbia Business School Measures Impact of New Cancer Drugs, Finds Most Significant Reduction in Mortality Rates 5-10 Years After Launch
Biopharmaceutical companies around the globe are increasing investment in and production of innovative cancer drug treatments.
CannaO2 Partners with Haystack Caps to Launch World's First Pocket-sized CBD-infused Oxygen Canister
Similar to an asthma inhaler, the new CBD-infused oxygen canister is tasteless, smokeless, and odorless
Global leaders, patient safety experts, hospital and medical technology CEOs and patient advocates will gather to address the challenges that cause medical errors and preventable deaths in hospitals worldwide at the 6th Annual World Patient Safety, Science & Technology Summit in London on February 23-25, 2018.
Sinovac Biotech announced today that it has received a positive decision from the WHO on the acceptability, in principle, of its Healive, a hepatitis A vaccine product, for purchase by United Nations agencies.
West Pharmaceutical Services, WHO Release: Study Demonstrates Benefit Of West's ID Adapter For Improving Intradermal Administration Of Polio Vaccine